Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.

被引：0
|
作者：
Gonsalves, Wilson I.
Rajkumar, S. Vincent
Timm, Michael
Morice, William
Dispenzieri, Angela
Lacy, Martha
Buadi, Francis
Dingli, David
Go, Ronald S.
Leung, Nelson
Kapoor, Prashant
Hayman, Suzanne R.
Lust, John Anthony
Russell, Stephen
Zeldenrust, Steven R.
Kourelis, Taxiarchis
Hwa, Yi Lisa
Kyle, Robert A.
Gertz, Morie A.
Kumar, Shaji
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_supp1.8015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8015
引用
收藏
页数：2
相关论文
共 45 条
  • [31] MULTIPARAMTER FLOW CYTOMETRY QUANTIFICATION OF BONE MARROW PLASMA CELLS AT DIAGNOSIS IS A VALID METHOD FOR PREDICTION OF MULTIPLE MYELOMA PATIENTS OUTCOME
    Paiva, B.
    Vidriales, M.
    Cervero, J.
    Mateo, G.
    Perez, J.
    Montalban, M. A.
    Sureda, A.
    Montejano, L.
    Gutierrez, N.
    Garcia de Coca, A.
    De las Heras, N.
    Mateos, M.
    Lopez-Berges, M.
    Garcia-Boyero, R.
    Galende, J.
    Hernandez, J.
    Palomera, L.
    Carrera, D.
    Martinez, R.
    De la Rubia, J.
    Martin, A.
    Blade, J.
    Lahuerta, J.
    Orfao, A.
    San Miguel, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 222 - 223
  • [32] Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma
    Abe, Yoshiaki
    Narita, Kentaro
    Kobayashi, Hiroki
    Kitadate, Akihiro
    Miura, Daisuke
    Takeuchi, Masami
    O'uchi, Eri
    O'uchi, Toshihiro
    Matsue, Kosei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (06) : 1325 - 1333
  • [33] Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma
    Yoshiaki Abe
    Kentaro Narita
    Hiroki Kobayashi
    Akihiro Kitadate
    Daisuke Miura
    Masami Takeuchi
    Eri O’uchi
    Toshihiro O’uchi
    Kosei Matsue
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1325 - 1333
  • [34] Single-Cell Spatial Proteomic Characterization of Clonal Plasma Cell and Immune Cell Metabolism within the Bone Marrow Microenvironment in High-Risk Smoldering Multiple Myeloma and Its Association with Progression to Multiple Myeloma
    Soekojo, Cinnie
    Geyer, Susan M.
    Guzman, Emmanuel Contreras
    Whitaker, Kaitlyn
    Kumar, Shaji
    Rajkumar, Vincent
    Cook, Joselle
    Chawla, Yogesh
    Buadi, Francis
    Dispenzieri, Angela
    Binder, Moritz
    Fonseca, Rafael
    Hitosugi, Taro
    Jevremovic, Dragan
    Gonsalves, Wilson I.
    Bisneto, Jose C. Villasboas
    BLOOD, 2024, 144 : 1881 - 1881
  • [35] Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis
    Liu, Xiaoyan
    Wu, Feifei
    Ye, Wu
    Deng, Jili
    Zhang, Mengmeng
    Zhang, Congli
    Yu, Qingfeng
    Cao, Li
    Gan, Silin
    Ma, Jie
    BMJ OPEN, 2024, 14 (01):
  • [36] Prognostic Relevance of Clonal Circulating Plasma Cells Detected By Multiparameter Flow Cytometry in Patients with Newly Diagnosed Multiple Myeloma Treated with Novel Agents: Comparative Investigation with the Revised International Staging System
    Abe, Yoshiaki
    Narita, Kentaro
    Kobayashi, Hiroki
    Kitadate, Akihiro
    Takeuchi, Masami
    Matsue, Kosei
    BLOOD, 2017, 130
  • [37] Evolving changes in M-protein (M), quantitative involved immunoglobulin (Ig), and hemoglobin (Hb) to identify patients (pts) with ultra high-risk smoldering multiple myeloma (UHR-SMM).
    Ravi, Praful Kumar
    Kumar, Shaji
    Larsen, Jeremy Todd
    Gonsalves, Wilson I.
    Buadit, Francis
    Lacy, Martha
    Go, Ronald S.
    Dispenzieri, Angela
    Kapoor, Prashant
    Lust, John Anthony
    Gertz, Morie A.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Next Generation Flow Cytometry Provides a Standardized, Highly Sensitive and Informative Method for the Analysis of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: A Single Center Study in 182 Patients
    Terpos, Evangelos
    Kostopoulos, Ioannis V.
    Papanota, Aristea-Maria
    Papadimitriou, Konstantinos
    Malandrakis, Panagiotis
    Micheli, Paraskevi
    Ntanasis-Stathopoulos, Ioannis
    Fotiou, Despina
    Metousis, Andreas
    Kanellias, Nikolaos
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Gavriatopoulou, Maria
    Kastritis, Eftathios
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios A.
    BLOOD, 2019, 134
  • [39] Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma
    Chandesris, M. O.
    Soulier, J.
    Labaume, S.
    Crinquette, A.
    Repellini, L.
    Chemin, K.
    Malphettes, M.
    Fieschi, C.
    Asli, B.
    Uzunhan, Y.
    Fermand, J. P.
    Bories, J. C.
    Arnulf, B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (04) : 609 - 614
  • [40] HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY
    Bertamini, L.
    Stefanoni, P.
    Tacchetti, P.
    Ledda, A.
    Palmas, A.
    Gentile, M.
    Palmieri, S.
    Annibali, O.
    Musolino, C.
    Burdisso, M.
    Capra, A.
    Rizzi, R.
    Molica, S.
    Cellini, C.
    Monaco, F.
    De Sabbata, G.
    Cea, M.
    Rivolti, E.
    Fazio, F.
    Musto, P.
    Boccadoro, M.
    Gay, F.
    HAEMATOLOGICA, 2021, 106 (10) : 12 - 13
12345